Amanote Research
Register
Sign In
Decreased Expression of Hsa‑miR‑372 Predicts Poor Prognosis in Patients With Gallbladder Cancer by Affecting Chloride Intracellular Channel 1
Molecular Medicine Reports
- Greece
doi 10.3892/mmr.2017.7520
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Date
May 1, 2017
Authors
Ning Zhou
Wei Cheng
Chuang Peng
Yi Liu
Bo Jiang
Publisher
Spandidos Publications
Related search
Low Mir-372 Expression Correlates With Poor Prognosis and Tumor Metastasis in Hepatocellular Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
Downregulation of Circulating Exosomal miR-638 Predicts Poor Prognosis in Colon Cancer Patients
Oncotarget
Oncology
Decreased Expression of miR-15b in Human Gliomas Is Associated With Poor Prognosis
Cancer Biotherapy and Radiopharmaceuticals
Nuclear Medicine
Radiology
Pharmacology
Cancer Research
Oncology
Imaging
Medicine
Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis
Oncology Letters
Cancer Research
Oncology
A High Monocyte-To-Lymphocyte Ratio Predicts Poor Prognosis in Patients With Advanced Gallbladder Cancer Receiving Chemotherapy
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Decreased Expression of CDH1 or CTNNB1 Affects Poor Prognosis of Patients With Esophageal Cancer
World Journal of Surgical Oncology
Surgery
Oncology
High Hepsin Expression Predicts Poor Prognosis in Gastric Cancer
Scientific Reports
Multidisciplinary
Golgi Phosphoprotein 3 Expression Predicts Poor Prognosis in Patients With Prostate Cancer Undergoing Radical Prostatectomy
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Elevated miR-301a Expression Indicates a Poor Prognosis for Breast Cancer Patients
Scientific Reports
Multidisciplinary